Physician profile
Mitchell R Heide
NPI 1073023248
$6,751.36
in general payments reported to CMS, 2019-2025
42 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $816 · 2022: $1,994 · 2023: $1,405 · 2024: $1,216 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,663 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,662.84 |
| Education | $278.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $934.24 | 2021-2025 | Padcev, Xtandi, Myrbetriq |
| Axonics, INC. | $716.00 | 2021-2024 | Axonics |
| Abbvie INC. | $685.64 | 2021-2025 | |
| Pfizer INC. | $559.79 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $470.63 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $363.72 | 2021-2025 | Speedicath, Titan, Luja Coude |
| 180 Medical, INC. | $291.86 | 2021-2024 | Gentlecath, Gentlecath Glide, Speedicath |
| Myriad Genetic Laboratories, INC. | $229.79 | 2021-2024 | Prolaris |
| Boston Scientific Corporation | $219.84 | 2021-2025 | Lithovue, Tria Firm, Spaceoar Vue System - 10ml |
| Endo Pharmaceuticals INC. | $198.64 | 2021-2022 | |
| Janssen Biotech, INC. | $195.75 | 2021-2025 | Erleada |
| Tolmar, INC. | $187.92 | 2023-2025 | Eligard, Jatenzo |
| Procept Biorobotics Corporation | $146.54 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $134.96 | 2022-2025 | Keytruda |
| Myovant Sciences INC. | $118.50 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $116.88 | 2022-2024 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $110.39 | 2023-2025 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $101.99 | 2024-2025 | Xiaflex, Aveed |
| Rochester Medical Corporation | $94.78 | 2021-2022 | |
| Ambu INC. | $92.88 | 2024 | |
| Hollister Incorporated | $68.52 | 2022-2024 | Vapro Pocket, Vapro |
| Novartis Pharmaceuticals Corporation | $62.36 | 2025 | |
| Urovant Sciences INC | $58.76 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $58.52 | 2023-2024 | Provenge |
| Ferring Pharmaceuticals INC. | $57.99 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $53.79 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.33 | 2022-2023 | |
| Medtronic, INC. | $49.80 | 2022-2023 | Interstim |
| Laborie Medical Technologies Corp. | $34.68 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $34.61 | 2023-2025 | Lynparza |
| Amgen INC. | $30.82 | 2022-2023 | Evenity, Prolia |
| Bioprotect Medical, INC. | $26.19 | 2025 | Bioprotect Balloon Implant System |
| Antares Pharma, INC. | $24.67 | 2021 | |
| Teleflex LLC | $24.60 | 2023 | Urolift |
| Inspire Medical Systems, INC. | $23.64 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $20.70 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $20.24 | 2021 | |
| Allergan, INC. | $20.11 | 2021 | |
| Abc Home Medical Supply, INC. | $16.95 | 2024 | |
| Clarus Therapeutics INC. | $15.34 | 2021 | |
| Photocure INC | $14.26 | 2022 | |
| Accord Healthcare, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Heide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.